This review deals with the neuronal mechanisms underlying spastic movement disorder, assessed by electrophysiological means with the aim of ®rst, a better understanding of the underlying pathophysiology and second, the selection of an adequate treatment. For the patient usually one of the ®rst symptoms of a lesion within the central motor system represents the movement disorder, which is most characteristic during locomotion in patients with spasticity. The clinical examination reveals exaggerated tendon tap re¯exes and increased muscle tone typical of the spastic movement disorder. However, today we know that there exists only a weak relationship between the physical signs obtained during the clinical examination in a passive motor condition and the impaired neuronal mechanisms being in operation during an active movement. By the recording and analysis of electrophysiological and biomechanical parameters during a functional movement such as locomotion, the signi®cance of, for example, impaired re¯ex behaviour or pathophysiology of muscle tone and its contribution to the movement disorder can reliably be assessed. Consequently, an adequate treatment should not be restricted to the cosmetic therapy and correction of an isolated clinical parameter but should be based on the pathophysiology and signi®cance of the mechanisms underlying the disorder of functional movement which impairs the patient. Spinal Cord (2000) 38, 389 ± 393
Introduction
Movement disorders are prominent features of impaired function of the motor systems and are frequently best re¯ected during gait. For the patient, the movement disorder usually represents the ®rst symptom for a lesion within the central motor system. The neurological examination is characterised by changes in re¯ex excitability and muscle tone and leads to an appropriate diagnosis underlying the gait disorder. The physical signs obtained during the clinical examination can, however, give little information about the pathophysiology underlying the movement disorder: stretch re¯ex excitability and muscle tone are basically dierent in the passive (clinical examination) compared to an active motor condition (movement). In addition, during a movement such as gait, several re¯ex systems are involved in its execution and control. Therefore, for adequate treatment of a movement disorder, we have to know about the function of re¯exes and supraspinal motor centres involved in the respective motor task. A movement such as locomotion is determined by the strength of electromyographic (EMG) activation of antagonistic leg muscles as well as intrinsic and passive muscle properties. The EMG activity recorded from the leg muscles re¯ects the action and interaction between central programs and aerent inputs from various sources which can only be separated to a limited degree. Therefore, for an assessment of the neuronal control of locomotor movements we have to record the EMG activity from several antagonistic leg muscles and the resulting biomechanical parameters such as joint movements and, eventually, of muscle tension. By such an approach it is possible to evaluate the behaviour of neuronal and biomechanical parameters during the gait disorder. Any changes in the neuronal or biomechanical systems may lead to the pathophysioloigcal basis of movement disorder. One has, however, to be aware that such deviations may already be secondary and compensatory to the primary dysfunction of the motor systems involved in the respective movement. This review is focused on the spastic movement disorder, the development of spasticity after an acute central motor lesion, the clinical signs and their relationship to the spastic movement disorder.
From spinal shock to spasticity
More than 100 years ago the term`spinal shock' was introduced to describe the clinical state in patients with acute spinal cord injury (SCI) presenting muscle paralysis with¯accid muscle tone and loss of tendon re¯exes below the level of lesion.
1 Although complete loss of sensorimotor function persists, spinal shock ends after some weeks and during the following months a`spastic syndrome' develops with exaggerated tendon re¯exes, increased muscle tone and involuntary muscle spasms. The development of a spastic syndrome is a common ®nding in surgically or pathologically con®rmed complete spinal cord transection, 2 ie, changes in the excitability of spinal cord neuronal circuits occur independently of supraspinal in¯uences. In a recent study 3 clinical and electrophysiological parameters were systematically assessed in patients after an acute SCI.
The period of spinal shock is electrophysiologically associated with a reduced excitability of alphamotoneurons (MN) re¯ected by a low persistence of F-waves (the F-wave is due to the antidromic excitation of MN following supramaximal electrical stimulation of a peripheral nerve), which is in line with previous studies. 4, 5 This observation may be related to the clinical signs found at this stage: the loss of tendon re¯exes and muscle hypotonia. The neurophysiological basis of the reduced alpha-MN excitability may be due to the sudden loss of tonic input and/or trophic support from supraspinal to spinal neuronal centres.
In contrast to the neuronal depression reported above, H-re¯exes can be elicited already at an early stage after SCI, 3 which is in accordance with earlier reports. 6 ± 8 The discrepancy between preserved H-re¯ex and the loss of tendon re¯exes as a typical clinical sign might at least partially be due to a reduced activity of gamma-motoneurons (gamma-MN).
While H-re¯ex was present early and F-wave persistence was low (but usually F-waves could be recorded), there is a loss of¯exor re¯ex activity in the tibialis anterior (TA) early after SCI. 3 The latter observation indicates a suppression of interneuronal (IN) activity mediating this polysynaptic re¯ex (for review see 9 ). The recovery from spinal shock is clinically re¯ected by an increase in the excitability of tendon tap re¯exes and in muscle tone (assessed by the Ashworth scale) as well as more frequently occurring muscle spasms (assessed by the Penn spasm frequency scale). These clinical changes are associated in the electrophysiological recordings by an increase of F-wave persistence and¯exor re¯ex activity.
3 There is only a minor change in H-re¯ex excitability during this time period. It may be suggested that the increase in tendon tap re¯ex excitability is at least partially due to a recovery of alpha-MN and probably also of gamma-MN function mediating this re¯ex. There is also an increase in¯exor re¯ex activity which should not only be due to a recovery of alpha-MN excitability, but also to the resolving depression of spinal interneuronal function. The pathway underlying thē exor re¯ex is a polysynaptic spinal one and allows the integration of inputs from muscles, joints and cutaneous aerents on common interneurons. 9 The changes in¯exor re¯ex excitability may at least partly be re¯ected in the appearance of muscle spasms. The increase in muscle tone may be due to a more general recovery of spinal neuronal (alpha-MN and IN) activity. Nevertheless, for both clinical parameters re¯ecting recovery from spinal shock (Penn spasm frequency and Ashworth scale) it cannot be ruled out that other factors than the neuronal activity recorded here, as well as changes of muscle biomechanics, contribute to the development of spasticity.
Clinically, the development of the spastic syndrome is characterised by exaggerated muscle tendon tap re¯exes, increased muscle tone and involuntary muscle contractions. The onset of spastic signs is dicult to determine because there is a smooth transition to a clearly established spasticity.
During this stage, both M-wave and¯exor re¯ex amplitudes remain about stable in tetraplegic or decrease in amplitude in paraplegic patients, ie, develop even opposite to the clinical signs. 3 A slight increase of H/M-ratio, which is in line with an earlier study, 10 might contribute to exaggerated tendon tap re¯exes. However, a correlation of this increase with the spastic state must be considered cautiously: (1) The high H/M-ratio can express rather a decrease of Mwave than an increase in re¯ex excitability; and (2) Short latency re¯ex hyperexcitability was shown to be little related to spastic muscle tone. 11 The fact that the decrease of M-wave and¯exor re¯ex amplitude is more pronounced in paraplegic than in tetraplegic patients indicates that several weeks after a SCI secondary, degenerations of spinal tracts occur including pre-motoneuronal circuits and alpha-MN. A direct damage of alpha-MN as an underlying cause is rather unlikely because M-wave amplitude increased up to the fourth week after SCI. Therefore, secondary degenerations are likely to depend on the level of lesion, ie, are less pronounced with higher level of lesion. The phenomenon of trans-synaptic degeneration of alpha-MN due to a degeneration of terminal synapses on a cell after SCI was already claimed earlier. 12 On the basis of the observations made in the study of Hiersemenzel et al 3 clinical signs of increasing spasticity, such as muscle tone and spasms, can hardly be related to the electrophysiological recordings. Secondary changes of motor units might contribute to the syndrome of spasticity, especially in respect to muscle tone and spasms.
Several studies claim that`peripheral changes' (eg, chronic transformation of muscle in spasticity) contribute to the increased muscle tone. 13, 14 A decrease of M-wave in patients with a SCI 15 or those with a cerebral lesion 16 indicates an aection of spinal
MN in the case of a disconnection from supraspinal input. Furthermore, signs of denervation are described to occur during the ®rst 2 months after SCI. 17 It became obvious during recent years that following a central motor lesion changes in mechanical muscle ®bre properties occur early after a lesion with the consequences of a signi®cant contribution to muscle tone in the active (for review see 18 ) and passive muscles 19 (for review see 11 and next sections).
Clinical spasticity
Spasticity produces numerous physical signs such as exaggerated re¯exes, clonus and muscle hypertonia. Clinically, spastic hypertonia has been de®ned as a resistance of passive muscle to stretch in a velocitydependent manner following activation of tonic stretch re¯exes. 20 On the basis of clinical observations a widely accepted conclusion was drawn for the pathophysiology of spasticity such that exaggerated re¯exes are responsible for the observed muscle hypertonia, and therefore the movement disorder.
Hyper¯exia is due to the neuronal reorganisation which occurs following central lesions in both cat 21 and man. 22 Novel connections may cause changes in the strength of re¯ex excitability. In addition, supersensitivity caused by the denervation may occur. 21 Although recent observations have indicated that central nervous lesions do not cause sprouting of primary aerents in either cat 23 or man, 24 changes in the reduction of pre-synaptic inhibition of group Ia ®bres occur 25 which correlate with the enhanced excitability of tendon tap re¯exes. In addition, reduction of pre-synaptic inhibition of group Ia aerents is stronger in patients with paraplegia compared to those with hemiplegia. 10 However, no correlation is seen between decreased presynaptic inhibition of Ia terminals and the degree of spastic muscle tone measured by Ashworth's scale. 10 Studies on muscle tone and re¯ex activity in patients with spastic hemiparesis following stroke have usually been performed under passive motor conditions. In such a condition a displacement of the elbow joint is associated with an increased EMG activity in the stretched muscles of the spastic side compared to the unaected side in patients with spastic hemiparesis. 19, 26 Nevertheless, subsequent studies analyzing the dierent components which contribute to muscle tone clearly revealed that muscle hypertonia is more associated with muscle ®bre contracture than with re¯ex hyperexcitability.
11,27
Studies on muscle tone and re¯ex activity have usually been performed under passive motor conditions. 26, 28 In such a condition, increased elbow torque following a displacement was associated with an increased EMG activity in the¯exor muscles of the spastic side compared to the unaected side in patients with spastic hemiparesis. 19 Nevertheless, spastic muscle hypertonia was found to be closely associated with muscle ®bre contracture but not with re¯ex hyperexcitability. 27 
Spastic gait disorder
Extensive investigations on functional movements of leg 13, 29, 30 and arm 19, 31, 32 muscles have not revealed any causal relationship between exaggerated re¯exes and spastic movement disorder. In patients with cerebral or spinal lesions the reciprocal mode of leg muscle activation during gait is preserved in spasticity. Exaggerated stretch re¯exes in spasticity are associated with an absence or reduction of functionally essential polysynaptic (long-latency) re¯exes. Both cutaneous 33 and stretch 34 re¯ex modulation are impaired in patients with spinal cord lesion during walking. In the latter experiments ankle joint rotations were induced in any phase of the step cycle. It was proposed that impaired modulation of the stretch re¯ex along with increased ankle joint stiness contribute to the impaired walking ability in spastic patients.
In spastic patients the EMG activity in the calf muscles during gait is smaller in amplitude and less well modulated compared to healthy subjects. 13 This observation is most probably due to the impaired function of polysynaptic re¯exes. Fast regulation of motoneuron discharge, which characterises the normal muscle, is absent in spasticity. 35, 36 This corresponds to a loss of EMG modulation during gait. In patients with spastic hemiparesis due to cerebral lesion, the strength of EMG activity in the aected leg is reduced compared to the unaected leg. This corresponds to the degree of paresis observed during both gait 29 and elbow movements. 31 Thus it becomes clear that inhibition and facilitation of spinal re¯exes depends upon supraspinal control which is impaired in spasticity.
In spastic paresis (acquired at an early or later stage), a fundamentally dierent development of tension of the triceps surae takes place during the stance phase of the stride cycle. 29, 30 In the unaected leg, the tension development correlates with the modulation of EMG activity (the same is true in healthy subjects) while in the spastic leg tension development is connected to the stretching period of the tonically activated (with small EMG amplitude) muscle. During gait there is no visible in¯uence of monosynaptic re¯ex potentials on the tension developed by the triceps surae. A similar discrepancy between the resistance to stretch and the level of EMG activity has been described for¯exor muscles of the upper limb in spastic patients. 37, 38 Muscle hypertonia in spastic patients is primarily associated with muscle contracture but not with exaggerated re¯exes. 11, 27 Muscle tone during functional movements in patients with spastic paresis cannot be explained by an increased activity of motoneurons assessed by EMG recordings. Instead, a transformation of motor units takes place such that a higher tension to EMG activity relationship occurs during the stretching phase of the triceps surae. This has the consequence that regulation of muscle tension takes place at a Spastic movement disorder V Dietz lower level of neuronal organisation. Therefore, the changed regulation of spastic gait should be considered as optimal for the given state of the motor system (cf. 39 ).
Motor unit transformation and spastic muscle tone
There are several ®ndings which support the suggestion that changes in mechanical muscle ®bre properties occur in spasticity. Contraction times in hand muscles 40 as well as in the gastrocnemius 41 in patients with spastic hemiparesis are prolonged. Torque motor experiments applied to upper and lower limb muscles indicate a major, non-re¯ex contribution to the spastic muscle tone in the antigravity muscles, ie, in the leg extensors and elbow¯exors. 42, 43 Histochemistry and morphometry studies of spastic muscle have revealed neurogenic changes of the muscle ®bres.
14,36 These include: (a) increased levels of muscle ®bre atrophy (especially of type II ®bres); (b) a predominance of type I ®bres in the gastrocnemius during later stages, when spasticity of cerebral origin has been established; (c) structural changes, such as the appearance of target ®bres, mainly in type I ®bres and (d) a signi®cant part of changes of mechanical muscle ®bre properties may be attributed to a shortening of muscle length as a result of a decrease in the number of sarcomeres in series along the myo®brils accompanied by an increase in resistance to stretch. 27 Such muscle contracture can be produced in experimental animal by plaster cast immobilisation of muscles in shortened positions.
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The alteration to a simpler regulation of muscle tension following paresis due to spinal or supraspinal lesions is basically advantageous for the patient as it enables him to support the body during gait and, consequently, to achieve mobility. 29 However, rapid movements are no longer possible due to the absence of modulation of muscle activity. Following a severe spinal or supraspinal lesion, these transformative processes can overshoot with unwelcome consequences, ie, painful spasms and involuntary movements.
Therapeutic consequences
The treatment of spasticity is usually directed towards reducing stretch re¯ex activity as it was thought that exaggerated re¯exes were responsible for increased muscle tone and therefore for spastic movement disorder.
However, therapeutic outcomes in spasticity should be considered in terms of physiotherapeutic approaches. These should be directed to train and activate residual motor functions (eg, 44 ) and to prevent secondary complications such as muscle contractures and spasms. More severely aected patients are usually less able to perform stepping movements as the spinal locomotor centres do not provide sucient basic activation of leg muscles. In recent years it has been shown that speci®c locomotor training could enhance locomotor activity and thereby improve mobility. 44, 45 Antispastic drug therapy is the second tool. It reduces muscle tone and spasms by the induction of a paresis which may interfere with the performance of functional movements. 46 Antispastic drug therapy is, therefore, predominantly of bene®t for immobilised patients in whom it reduces muscle tone and relieves muscle spasms, both of which may also improve nursing care for these patients.
Conclusions
In patients with spastic paresis, the central programming, with the timing and reciprocal mode of leg muscle activation during gait, is basically intact. Exaggerated monosynaptic re¯exes are associated with a loss of the functionally essential polysynaptic re¯ex mechanisms, both being dependent on supraspinal control. When this control is impaired, inhibition of monosynaptic stretch re¯exes is missing in combination with a reduced facilitation of polysynaptic re¯exes.
A spinal or cerebral lesion, associated with paresis, is followed by a transformation of motor units and shortening of muscle ®bres, leading to a (subclinical) muscle contracture, such that tension development in the antigravity muscle occurs in a simpler fashion. Development of tension by the calf muscles during gait is normally determined by modulated gastrocnemius/ soleus electromyographic activity. In the spastic leg, calf muscle tension is associated with the stretching of the tonically activated muscle. This regulation of muscle tension at a lower level is ecient in so far as it enables the patient to support body weight during gait.
Consequently, in mobile patients primarily physiotherapeutic approaches should be applied, while antispastic during therapy represents a second tool. Only in immobilised patients could antispastic drugs be of bene®t to relieve muscle spasms and improvement of nursing care.
